NCT01571531 European Multicentre Study of Human Spinal Cord Injury
| NCT ID | NCT01571531 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Zurich |
| Condition | Spinal Cord Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2004-04 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,000 participants in total. It began in 2004-04 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Today there is accumulating evidence from animal experiments that regeneration can be induced after a spinal cord injury (SCI). Consequently in the near future, new therapeutic approaches to induce some regeneration will be included in the treatment of patients with SCI. The aim of this proposal is to provide the required clinical basis for the implementation of novel interventional therapies. The establishment of combined clinical, functional and neurophysiological measures for a qualitative and quantitative assessment of spinal cord function in patients with SCI at different stages during rehabilitation represents a basic requirement to monitor any significant effect of a new treatment. Therefore, several European Paraplegic Centres involved in the rehabilitation of acute traumatic SCI patients build up a close collaboration for standardised assessment. The aim is to get knowledge about the natural recovery after spinal cord lesion in a larger population of patients in the sense of a historical control group and to bring new standardised assessment tools to the clinical setting.
Eligibility Criteria
Inclusion Criteria: * Single event traumatic or ischemic para- or tetraplegia * First EMSCI assessment possible within the first 6 weeks after incidence * Patient capable and willing of giving written informed consent Exclusion Criteria: * Nontraumatic para- or tetraplegia (i.e. discusprolaps, tumor, AV-malformation, myelitis) excl. single event ischemic incidences * Pre-known dementia or severe reduction of intelligence, leading to reduced capabilities of cooperation or giving consent * Peripheral nerve lesions above the level of lesion (i.e. plexus brachialis impairment) * Pre-known polyneuropathy * Severe craniocerebral injury
Contact & Investigator
Armin Curt, Prof., MD
PRINCIPAL INVESTIGATOR
University of Zurich
Frequently Asked Questions
Who can join the NCT01571531 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01571531 currently recruiting?
Yes, NCT01571531 is actively recruiting participants. Contact the research team at armin.curt@balgrist.ch for enrollment information.
Where is the NCT01571531 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT01571531 clinical trial?
NCT01571531 is sponsored by University of Zurich. The principal investigator is Armin Curt, Prof., MD at University of Zurich. The trial plans to enroll 8,000 participants.